Literature DB >> 18609716

1,25-dihydroxyvitamin D(3) regulates LPS-induced cytokine production and reduces mortality in rats.

Xiao-Ping Qi1, Pei Li, Gang Li, Zhen Sun, Jie-Shou Li.   

Abstract

AIM: To study the immunoregulatory effect of 1,25-dihydroxyvitamin-D(3) Von dominant Th1 response in rats.
METHODS: Sixty adult Lewis rats were randomized into three groups. Rats in group 1 (n=25) were treated with 1,25-(OH)(2)D(3) first and then challenged with LPS, rats in group 2 (n=25) were treated with vehicle first and then challenged with LPS. Ten animals in groups 1 and 2 were preserved for mortality observation. The remaining animals were injected (i.p) with endotoxin, 24 h after the last administration of 1,25-(OH)(2)D(3) and vehicle. Rats in group 3 (n=10) were treated with 1,25-(OH)(2)D(3) only. Serum IL-12, IFN-gamma, IL-2 and IL-4 levels were measured and target gene of 1,25-(OH)(2)D(3) on Th cells was studied after 6 h. Gene abundance was verified by real-time quantitative PCR.
RESULTS: No death occurred in rats pretreated with 1,25-(OH)(2)D(3) after LPS injection. Death occurred 9 h after LPS injection in rats pretreated with the vehicle, and the number of deaths was 5 within 24 h, with a mortality rate of 50%. There was no change in the number of deaths within 96 h. Six hours after endotoxin stimulation, serum IL-12 and IFN-gamma levels decreased significantly in rats pretreated with 1,25-(OH)(2)D(3) as compared with those in rats pretreated with the vehicle. The serum content of these two cytokines was very low in rats not challenged by endotoxin, and there was a significant difference as compared with the previous two groups.
CONCLUSION: 1,25-(OH)(2)D(3) attenuates injury induced by the lethal dose of LPS, regulates Th1 and Th2 cells at the transcription level, and dominantly responds to cytokine production in rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18609716      PMCID: PMC2721449          DOI: 10.3748/wjg.14.3897

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells.

Authors:  Teodora P Staeva-Vieira; Leonard P Freedman
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

Review 2.  The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents.

Authors:  Chantal Mathieu; Luciano Adorini
Journal:  Trends Mol Med       Date:  2002-04       Impact factor: 11.951

3.  NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription.

Authors:  Silvia Monticelli; Anjana Rao
Journal:  Eur J Immunol       Date:  2002-10       Impact factor: 5.532

4.  Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10.

Authors:  Alla Skapenko; Gerald U Niedobitek; Joachim R Kalden; Peter E Lipsky; Hendrik Schulze-Koops
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 5.  Pharmacological induction of tolerogenic dendritic cells and regulatory T cells.

Authors:  Luciano Adorini; Nadia Giarratana; Giuseppe Penna
Journal:  Semin Immunol       Date:  2004-04       Impact factor: 11.130

Review 6.  Role of IFN-gamma in allograft rejection.

Authors:  Luis G Hidalgo; Philip F Halloran
Journal:  Crit Rev Immunol       Date:  2002       Impact factor: 2.214

Review 7.  1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation.

Authors:  Luciano Adorini
Journal:  Curr Opin Investig Drugs       Date:  2002-10

8.  The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells.

Authors:  Brett D Mahon; Anja Wittke; Veronika Weaver; Margherita T Cantorna
Journal:  J Cell Biochem       Date:  2003-08-01       Impact factor: 4.429

9.  Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.

Authors:  W F Rigby; S Denome; M W Fanger
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

Review 10.  Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases.

Authors:  Luciano Adorini
Journal:  Int Immunopharmacol       Date:  2002-06       Impact factor: 4.932

View more
  4 in total

1.  Effect of vitamin D supplementation on cathelicidin, IFN-γ, IL-4 and Th1/Th2 transcription factors in young healthy females.

Authors:  M Das; N Tomar; V Sreenivas; N Gupta; R Goswami
Journal:  Eur J Clin Nutr       Date:  2014-01-08       Impact factor: 4.016

2.  Vitamin d and serum cytokines in a randomized clinical trial.

Authors:  Eleanor Yusupov; Melissa Li-Ng; Simcha Pollack; James K Yeh; Mageda Mikhail; John F Aloia
Journal:  Int J Endocrinol       Date:  2010-08-12       Impact factor: 3.257

3.  Different doses of supplemental vitamin D maintain interleukin-5 without altering skeletal muscle strength: a randomized, double-blind, placebo-controlled study in vitamin D sufficient adults.

Authors:  Tyler Barker; Thomas B Martins; Harry R Hill; Carl R Kjeldsberg; Vanessa T Henriksen; Brian M Dixon; Erik D Schneider; Adam Dern; Lindell K Weaver
Journal:  Nutr Metab (Lond)       Date:  2012-03-09       Impact factor: 4.169

4.  Calcitriol inhibits osteoclastogenesis in an inflammatory environment by changing the proportion and function of T helper cell subsets (Th2/Th17).

Authors:  Chun-Sheng Bi; Xuan Li; Hong-Lei Qu; Li-Juan Sun; Ying An; Yong-Long Hong; Bei-Min Tian; Fa-Ming Chen
Journal:  Cell Prolif       Date:  2020-05-13       Impact factor: 6.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.